Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Change in Account Payables (2016 - 2026)

Intellia Therapeutics has reported Change in Account Payables over the past 12 years, most recently at -$1.4 million for Q1 2026.

  • Quarterly Change in Account Payables rose 24.02% to -$1.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.4 million through Mar 2026, up 1108.78% year-over-year, with the annual reading at $6.0 million for FY2025, 11.96% down from the prior year.
  • Change in Account Payables was -$1.4 million for Q1 2026 at Intellia Therapeutics, down from $7.0 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $7.0 million in Q4 2025 and troughed at -$7.7 million in Q3 2023.
  • The 5-year median for Change in Account Payables is $750000.0 (2022), against an average of $547352.9.
  • The largest YoY upside for Change in Account Payables was 2152.63% in 2023 against a maximum downside of 374.51% in 2023.
  • A 5-year view of Change in Account Payables shows it stood at $750000.0 in 2022, then soared by 425.47% to $3.9 million in 2023, then crashed by 63.56% to $1.4 million in 2024, then skyrocketed by 384.61% to $7.0 million in 2025, then tumbled by 120.41% to -$1.4 million in 2026.
  • Per Business Quant, the three most recent readings for NTLA's Change in Account Payables are -$1.4 million (Q1 2026), $7.0 million (Q4 2025), and $3.5 million (Q3 2025).